Old LJ - Search Results

1

Cross-presentation of HLA class I epitopes from exogenous NY-ESO-1 polypeptides by nonprofessional APCs.

Gnjatic S, Atanackovic D, Matsuo M, Jäger E, Lee SY, Valmori D, Chen YT, Ritter G, Knuth A, Old LJ. Gnjatic S, et al. Among authors: old lj. J Immunol. 2003 Feb 1;170(3):1191-6. doi: 10.4049/jimmunol.170.3.1191. J Immunol. 2003. PMID: 12538675

2

CD4+ CD25+ regulatory T cells control the induction of antigen-specific CD4+ helper T cell responses in cancer patients.

Nishikawa H, Jäger E, Ritter G, Old LJ, Gnjatic S. Nishikawa H, et al. Among authors: old lj. Blood. 2005 Aug 1;106(3):1008-11. doi: 10.1182/blood-2005-02-0607. Epub 2005 Apr 19. Blood. 2005. PMID: 15840697 Free article.

3

Identification of B cell epitopes recognized by antibodies specific for the tumor antigen NY-ESO-1 in cancer patients with spontaneous immune responses.

Valmori D, Souleimanian NE, Hesdorffer CS, Ritter G, Old LJ, Ayyoub M. Valmori D, et al. Among authors: old lj. Clin Immunol. 2005 Oct;117(1):24-30. doi: 10.1016/j.clim.2005.05.003. Clin Immunol. 2005. PMID: 15994128

4

Influence of CD4+CD25+ regulatory T cells on low/high-avidity CD4+ T cells following peptide vaccination.

Nishikawa H, Qian F, Tsuji T, Ritter G, Old LJ, Gnjatic S, Odunsi K. Nishikawa H, et al. Among authors: old lj. J Immunol. 2006 May 15;176(10):6340-6. doi: 10.4049/jimmunol.176.10.6340. J Immunol. 2006. PMID: 16670346

5

NY-ESO-1: review of an immunogenic tumor antigen.

Gnjatic S, Nishikawa H, Jungbluth AA, Güre AO, Ritter G, Jäger E, Knuth A, Chen YT, Old LJ. Gnjatic S, et al. Among authors: old lj. Adv Cancer Res. 2006;95:1-30. doi: 10.1016/S0065-230X(06)95001-5. Adv Cancer Res. 2006. PMID: 16860654 Review.

6

Tumor-reactive CD8+ T-cell clones in patients after NY-ESO-1 peptide vaccination.

Karbach J, Gnjatic S, Pauligk C, Bender A, Maeurer M, Schultze JL, Nadler K, Wahle C, Knuth A, Old LJ, Jäger E. Karbach J, et al. Among authors: old lj. Int J Cancer. 2007 Nov 1;121(9):2042-2048. doi: 10.1002/ijc.22957. Int J Cancer. 2007. PMID: 17640060

7

NY-ESO-1 DNA vaccine induces T-cell responses that are suppressed by regulatory T cells.

Gnjatic S, Altorki NK, Tang DN, Tu SM, Kundra V, Ritter G, Old LJ, Logothetis CJ, Sharma P. Gnjatic S, et al. Among authors: old lj. Clin Cancer Res. 2009 Mar 15;15(6):2130-9. doi: 10.1158/1078-0432.CCR-08-2632. Epub 2009 Mar 10. Clin Cancer Res. 2009. PMID: 19276258 Free PMC article. Clinical Trial.

8

Characterization of preexisting MAGE-A3-specific CD4+ T cells in cancer patients and healthy individuals and their activation by protein vaccination.

Tsuji T, Altorki NK, Ritter G, Old LJ, Gnjatic S. Tsuji T, et al. Among authors: old lj. J Immunol. 2009 Oct 1;183(7):4800-8. doi: 10.4049/jimmunol.0900903. Epub 2009 Sep 4. J Immunol. 2009. PMID: 19734225

9

Antibody-targeted NY-ESO-1 to mannose receptor or DEC-205 in vitro elicits dual human CD8+ and CD4+ T cell responses with broad antigen specificity.

Tsuji T, Matsuzaki J, Kelly MP, Ramakrishna V, Vitale L, He LZ, Keler T, Odunsi K, Old LJ, Ritter G, Gnjatic S. Tsuji T, et al. Among authors: old lj. J Immunol. 2011 Jan 15;186(2):1218-27. doi: 10.4049/jimmunol.1000808. Epub 2010 Dec 13. J Immunol. 2011. PMID: 21149605

10

Heat shock protein 90-mediated peptide-selective presentation of cytosolic tumor antigen for direct recognition of tumors by CD4(+) T cells.

Tsuji T, Matsuzaki J, Caballero OL, Jungbluth AA, Ritter G, Odunsi K, Old LJ, Gnjatic S. Tsuji T, et al. Among authors: old lj. J Immunol. 2012 Apr 15;188(8):3851-8. doi: 10.4049/jimmunol.1103269. Epub 2012 Mar 16. J Immunol. 2012. PMID: 22427632

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

735 results

Search Page

Filters